AMPH Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: ACCESS Newswire

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

6 days ago - By: Benzinga

The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts

7 days ago - By: ACCESS Newswire

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

7 days ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

7 days ago - By: Zacks Investment Research - Mentions: CVAC

Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates

7 days ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

2 months ago - By: Zacks Investment Research

Is the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock?

9 days ago - By: Zacks Investment Research - Mentions: PSNL

Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates

14 days ago - By: Zacks Investment Research - Mentions: SUPN

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

17 days ago - By: ACCESS Newswire

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

3 months ago - By: ACCESS Newswire

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

24 days ago - By: Zacks Investment Research - Mentions: PFE CRMD

How Will DefenCath Aid CRMD's Top Line in the Upcoming Q3 Results?

2 months ago - By: Zacks Investment Research - Mentions: PFE CRMD

CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock?